SCHEMBL10664993

SCHEMBL10664993

CN(CCC(=O)C(Cc1ccccc1)NC(=O)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 18/20 0.73
▸ ACE2 Q9BYF1 10/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10664899 0.91 ACE (0.72) ACEACE2
SCHEMBL10847107 0.91 ACE (0.72) ACEACE2
SCHEMBL10848104 0.88 ACE (0.58) ACEACE2
SCHEMBL10669883 0.85 ACE (0.71) ACEACE2
SCHEMBL1792093 0.84 ACE (1.00) ACEACE2
SCHEMBL11123161 0.84 ACE (1.00) ACEACE2
SCHEMBL1792089 0.84 ACE (1.00) ACEACE2
SCHEMBL7360582 0.84 ACE (0.74) ACEACE2
SCHEMBL7360576 0.84 ACE (0.74) ACEACE2
Hydrochloric Acid SCHEMBL9536922 0.83 ACE (0.73) ACEACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4742067-A Acylalkylaminocarbonyl substituted amino and imino acid compounds E. R. SQUIBB & SONS, INC. (US) 1988-05-03 — — US disclosed
US-4623729-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1986-11-18 — — US disclosed
US-4621092-A HYPOTENSIVE, ANALGESIC E. R. SQUIBB & SONS, INC. (US) 1986-11-04 — — US disclosed
US-4604402-A HYPOTENSIVE AGNETS E. R. SQUIBB & SONS, INC. (US) 1986-08-05 — — US disclosed
EP-0159156-A1 Hydroxy substituted ureido amino and imino acids E.R. Squibb & Sons, Inc. (US) 1985-10-23 — — EP disclosed
EP-0103496-A1 Acylalkylaminocarbonyl substituted amino and imino acid compounds E.R. Squibb & Sons, Inc. (US) 1984-03-21 — — EP disclosed
Send feedback